{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:32:57Z","timestamp":1781105577681,"version":"3.54.1"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We present a 24-year-old man with a history of metastatic nasopharyngeal cancer. Despite receiving standard treatments, including surgery, radiotherapy, and chemotherapy, he has shown progression. Consequently, he has been referred to the nuclear medicine department for theranostic purposes. The <jats:sup>99m<\/jats:sup>Tc-FAPI-46 whole-body scan showed tracer uptake in mediastinal large mass, both external lymph nodes and osseous metastases. Treatment with <jats:sup>177<\/jats:sup>Lu-FAPI-2286 initiated, with subsequent planar scans revealing sustained uptake up to day 10, particularly in the large mediastinal mass. This case indicates promising FAPI-targeted theranostic potential in metastatic nasopharyngeal carcinoma and proper retention of <jats:sup>177<\/jats:sup>Lu-FAPI-2286 in metastatic lesions.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005662","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:16Z","timestamp":1737676816000},"page":"e379-e380","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["99mTc-FAPI-46 Scan and 177Lu-FAPI-2286 Treatment in a Patient With Nasopharyngeal Carcinoma"],"prefix":"10.1097","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3507-2077","authenticated-orcid":false,"given":"Somaye","family":"Barashki","sequence":"first","affiliation":[{"name":"Nuclear Medicine Research Center, Mashhad University of Medical Science, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bentolhoda","family":"Hadad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Raeisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Aryana","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Research Center, Mashhad University of Medical Science, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"bib1-20250613","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1038\/s41598-023-30806-6","article-title":"A novel molecular imaging probe [99mTc] Tc-HYNIC-FAPI targeting cancer-associated fibroblasts","volume":"13","author":"Jiang","year":"2023","journal-title":"Sci Rep"},{"key":"bib2-20250613","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/prca.201300095","article-title":"Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy","volume":"8","author":"Hamson","year":"2014","journal-title":"Proteomics Clin Appl"},{"key":"bib3-20250613","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fcell.2018.00048","article-title":"Hyaluronan, cancer-associated fibroblasts and the tumor microenvironment in malignant progression","volume":"6","author":"McCarthy","year":"2018","journal-title":"Front Cell Dev Biol"},{"key":"bib4-20250613","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.3390\/diagnostics13122018","article-title":"FAPI PET\/CT imaging\u2014an updated review","volume":"13","author":"Chandekar","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"bib5-20250613","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.2967\/jnumed.119.239731","article-title":"Design and development of 99mTc-labeled FAPI tracers for SPECT imaging and 188Re therapy","volume":"61","author":"Lindner","year":"2020","journal-title":"J Nucl Med"},{"key":"bib6-20250613","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.7150\/thno.69475","article-title":"Fibroblast activation protein-based theranostics in cancer research: a state-of-the-art review","volume":"12","author":"Zhao","year":"2022","journal-title":"Theranostics"},{"key":"bib7-20250613","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2967\/jnumed.119.241232","article-title":"FAP: the next billion dollar nuclear theranostics target?","volume":"61","author":"Calais","year":"2020","journal-title":"J Nucl Med"},{"key":"bib8-20250613","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s00259-023-06144-0","article-title":"Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies","volume":"23","author":"Priv\u00e9","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib9-20250613","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40658-022-00497-5","article-title":"Impact of radiopharmaceutical therapy (177Lu, 225Ac) microdistribution in a cancer-associated fibroblasts model","volume":"9","author":"Tranel","year":"2022","journal-title":"EJNMMI Phys"},{"key":"bib10-20250613","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s00259-021-05634-3","article-title":"FAP-targeted radionuclide therapy with [177Lu]Lu-FAPI-46 in metastatic nasopharyngeal carcinoma","volume":"49","author":"Fu","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib11-20250613","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1097\/RLU.0000000000004051","article-title":"Fibroblast activation protein inhibitor imaging and therapy in a patient with multiple endocrine neoplasia type 2A syndrome","volume":"47","author":"Barashki","year":"2022","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005662","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T12:00:51Z","timestamp":1749816051000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005662","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"2024-08-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}